|2nd October 2020||Leslie D. Funtleyder||5,976||Open or private sale||$20.07||$119,938.32|
|1st October 2020||Leslie D. Funtleyder||30,000||Exercise of derivative||$4.70||$141,000.00|
|1st October 2020||Leslie D. Funtleyder||22,671||Open or private sale||$20.03||$454,100.13|
|1st October 2020||Leslie D. Funtleyder||1,353||Open or private sale||$20.75||$28,074.75|
|24th August 2020||Leslie D. Funtleyder||13,539||Open or private sale||$23.42||$317,083.38|
|24th August 2020||Leslie D. Funtleyder||6,461||Open or private sale||$24.18||$156,226.98|
|21st August 2020||Leslie D. Funtleyder||20,000||Exercise of derivative||$4.70||$94,000.00|
|17th August 2020||Joel S Marcus||3,500||Open or private sale||$173.51||$607,285.00|
|17th August 2020||Joel S Marcus||4,000||Open or private sale||$171.52||$686,080.00|
|12th August 2020||Joel S Marcus||7,959||Open or private sale||$14.15||$112,619.85|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company was founded by Shoshana Shendelman on January 20, 2016.